Advanced hepatocellular carcinoma with MET-amplified contained excellent response to crizotinib: a case report

INTRODUCTION: Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide. Several novel therapeutic strategies have been developed to prolong the survival of patients with advanced HCC. However, therapeutic decision-making biomarkers owing to the extensive heterogeneity of HCC. Next-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yangjun, Xiao, Min, Chen, Zhitao, Li, Qiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467267/
https://www.ncbi.nlm.nih.gov/pubmed/37655101
http://dx.doi.org/10.3389/fonc.2023.1196211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467267/
https://www.ncbi.nlm.nih.gov/pubmed/37655101
http://dx.doi.org/10.3389/fonc.2023.1196211

Ejemplares similares